x 

0 Activities
0 Activities
    • No Saved Activities

Oncology

  2. Home
  3. Education
  4. Top Specialty Areas
  5. Oncology
  6. Disease Area
  7. Idiopathic Pulmonary Fibrosis

Search

Filter Content

Idiopathic Pulmonary Fibrosis

Free online continuing education on Idiopathic Pulmonary Fibrosis! Get quality activities, articles, & videos to improve your Idiopathic Pulmonary Fibrosis education.

Page 1 of 2
Results 1 - 75 of 112
9102-chest-slides
IPF Management and Antifibrotic Therapy - Slide Deck
9088-ipf-slides
A Collaborative Approach to IPF Management - Slide Deck
9101-chest
IPF Management and Antifibrotic Therapy
No image set
A Collaborative Approach to IPF Management
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
Management of Patients With IPF: Virtual Conference Coverage
No image set
Clinical Pearls from New Orleans 2019
No image set
Inhaled NO in Patients at Risk for Pulmonary Hypertension
No image set
Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease
No image set
Considerations for Geriatric ILD Patients
No image set
Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease
No image set
Emerging Diagnostic Approaches to Patients with ILD
No image set
Goals of Care Across the Disease Continuum in IPF
No image set
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
No image set
Current Perspective on Antifibrotic Therapy for Patients with IPF
No image set
Pulmonologists as the Gatekeepers of Precision Medicine
No image set
Interstitial Pneumonia with Autoimmune Features (IPAF)
No image set
How to Identify & Manage Patients with Progressive-Fibrosing ILD
9840-0004-icon
Acute Exacerbations of IPF
9815-developments
New Developments in Pulmonary Diseases: Optimizing Patient Outcomes
9815-palliative slides
Palliative Medicine in Pulmonology
No image set
Thoracic Radiology
9916-0002_moa3
Mechanisms of Action of Biologic Therapies for Severe Asthma
9907-0006_shared
Engage Your Patients in Shared Decision-Making
9907-0005_cardio
Is It IPF or Cardiovascular Disease?
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics?
9916-brown5
The Impact of Anticoagulation Use on IPF Patient Outcomes
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
9840-glassberg2
Evaluation and Diagnosis of IPF
9840-glassberg1
Initial Treatment Decisions of IPF
9840-0003
Optimizing Management of IPF
9916-king
What are the Most Exciting Things Happening in Pulmonary Disease?
No image set
When Is a Cough Not Just a Cough?
No image set
Diagnosing ILDs Such as IPF and More
No image set
Beyond the Basics: Complex ILD Cases
9815-jane
Shedding Light on Jane’s ILD Diagnosis
9815-palliative
When Should You Consider Palliative Care in the Patient Journey?
9815-sandra
What is Your Treatment Recommendation for Sandra’s CTEPH?
9815-tracy
Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?
9916-scholand
New Tools to Improve the Diagnosis of IPF vs Other ILDs
9916-brown
New Research on Therapies for Patients with Pulmonary Fibrosis
9916-richeldi
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
9916-cc-cme
2019 Summer Pulmonary Updates: The Experts Weigh In
No image set
Reporting HRCT Findings for ILD from a Multidisciplinary Team
9816-0001
The Latest from a Recent Pulmonary Conference in San Antonio
9816-0009
The Importance of Early Integration of Palliative Care
9816-0006
Management of IPF Patients in 2018
9816-0005
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
9816-00045
Overview of the Latest Clinical Trials in IPF
9816-0003
Evolution of Antifibrotic Therapy in IPF
9816-0002
Take Home Messages from the 2018 CHEST Annual Meeting
9816-0008
What We’re Learning from the IPF-PRO Registry
9816-0007
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
Practice_Improvement_through_ILD_Centers_264x150
Practice Improvement through ILD Centers and Community Partnerships
Improving_the_Care_for_IPF_Patients_264x150
Improving the Care for IPF Patients Using a Team-Based Approach
An_Early_Integrated_Palliative_Care_264x150
An Early Integrated Palliative Care Delivery Model for Patients with IPF
No image set
Exploring the Patient Journey with Problem-Based Learning
No image set
Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
No image set
Environmental Influences on the Development of Pulmonary Fibrosis
No image set
Gene Abnormalities and ILD
No image set
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
Page 1 of 2

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA

Search